Femalegra 100 Mg With Sildenafil Citrate
Product highlights
Description
Femalefil 10 mg is a prescription medication formulated to aid women with low sexual arousal. It contains 10 mg of FDA-approved Tadalafil, a Phosphodiesterase Type 5 (PDE5) inhibitor. Sunrise Remedies Pvt. Ltd. manufactures the medication in a GMP-compliant facility.
Tadalafil acts by blocking the PDE5 enzyme, which breaks down cyclic Guanosine Monophosphate (cGMP) in penile blood vessels. Femalefil inhibits PDE5, which helps sustain higher cGMP levels, leading to the relaxation of pelvic region smooth muscle. This, in turn, enhances blood flow, leading to vaginal engorgement and arousal.
The prescribed dosage is one 10 mg tablet, taken orally with water, usually 30-60 minutes before sexual activity. Do not have more than one pill in 24 hours. Since the medication is to be used as needed, a missed dosage is not applicable in this case. However, in case of an overdose, reach out to your doctor immediately if you experience severe dizziness, chest discomfort, or irregular heartbeat.
What are the benefits of taking Femalefil 10 mg
Femalefil 10 mg tablets contain Tadalafil, which improves vaginal sensitivity, lubrication, and general arousal in women with Low Libido. Tadalafil is a PDE5 inhibitor that blocks the PDE5 enzyme, causing smooth muscles and blood vessels to relax. This, in turn, increases blood flow to the genitals. By relaxing smooth muscles and boosting natural responses, it helps women experience stronger desire and better intimate satisfaction.
The primary benefits of this pill include:
- Improved sexual desire
- Better vaginal lubrication
- Enhanced ability to achieve sexual satisfaction
- Increased genital sensitivity
Key benefits
Directions for use
Use as directed on the product label, or as advised by your healthcare provider.
Safety information
Chat with us
Product details
| Brand | Capsule |
|---|---|
| Manufacturer | QuickCure Distribution LLC |
| Country of Origin | USA |
| Expiry Date | Best before 24 months from manufacture |